RPC
WGS icon

Rossmore Private Capital’s GeneDx Holdings WGS Stock Holding History

Rossmore Private Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-807
Closed -$23K – 232
2022
Q3 		$23K Hold
807
– – ﹤0.01% 219
2022
Q2 		$34K Hold
807
– – 0.01% 224
2022
Q1 		$82K Buy
+807
New +$89.7K 0.01% 222

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rossmore Private Capital's WGS Position: Q4 2022 in Review

Rossmore Private Capital sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 807 shares — an estimated $23K sold.

Rossmore Private Capital first reported a position in WGS in Q1 2022 and held it in 3 quarters. The position peaked at $82K in Q1 2022. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

  • Rossmore Private Capital reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
  • Rossmore Private Capital sold 807 GeneDx Holdings shares in Q4 2022, an estimated $23K.
  • Rossmore Private Capital first reported a position in GeneDx Holdings in Q1 2022 and held it in 3 quarters.
  • Rossmore Private Capital's GeneDx Holdings position peaked at $82K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on Rossmore Private Capital's 13F filing for Q4 2022, filed 14 Feb 2023.